Concepedia

Diane Miller

DM

Statistics

Publications

10

Citations

2.4K

H-Index

10

Active since

2000

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

University of Toronto

Lund University

St. Michael's Hospital

Diane Miller is an author at GlaxoSmithKline (United States) specializing in medicine, diabetes, and clinical trials.

Top concepts

Publications per year

2000–2020

10

Publications

10

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

, , +6

Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism

Andrew Wang, Terry L. Holcslaw, Thomas M. Bashore et al. · Kidney International · 2000 · 232 citations

, , +4

Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro

Julio Rosenstock, Vivian Fonseca, Jorge Luiz Gross et al. · Diabetes Care · 2014 · 202 citations

Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Hertzel C. Gerstein, Robert E. Ratner, Christopher P. Cannon et al. · Circulation · 2010 · 101 citations · Full text

Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy

Philip Home, Bo Åhrén, Jane E.B. Reusch et al. · Diabetes Research and Clinical Practice · 2017 · 39 citations

, , +5

1–5 of 10